Revolutionising cellular therapies for cancer and beyond
We’re developing more precise and more accessible treatment options for patients with solid cancers, endometriosis and Alzheimer’s disease
Pioneering excellence in the field of immunotherapy
Cartherics creates precisely-defined immunotherapy treatments to combat a variety of cancers, endometriosis and Alzheimer’s disease. We combine the best components of immune targeting utilising gene editing and CAR technology to advance cell therapy to provide more diverse off-the-shelf treatments for patients. Our team has strong backgrounds in research, development, and product commercialisation. And we partner with leading commercial and academic groups with complementary technology to push the boundaries of cell therapy for cancer and beyond.
Some of our partners
Latest news
Cartherics CEO handed the editorial chair
By Christine Filippis / November 9, 2020
Alan Trounson guest edits a special immunology issue of the journal Cells By Leigh Dayton 9 Nov 2020 As well...
Read More
Nobel Chemistry prize going to CRISPR scientists
By Christine Filippis / October 9, 2020
Genetic scissors: a tool for rewriting the code of life wins the 2020 Nobel Prize for Chemistry Emmanuelle Charpentier and...
Read More
Good news from Cartherics. The company’s off-the-shelf immune therapy for ovarian cancer is close to clinical trials
By Christine Filippis / September 23, 2020
View the article in the CRC (Cooperative Research Centres Association) Association Newsletter here : CRC Association Newsletter Cartherics’ cost-effective ‘off-the-shelf’...
Read More
